Idexx Laboratories — Q2 2024 Earnings Presentation

4 slides from Idexx Laboratories's earnings presentation, Aug 6, 2024

Slide 1: IDEXX Q2 2024 Earnings Highlights
IDEXX Q2 2024 Earnings Highlights (NASDAQ: (NASDAQ: IDXX) IDXX) Operating Diluted Revenue Profit Earnings Per Share $1,004M $264M $2.44 Reported growth: +6% 26.3% of Revenue Reported growth: (9%) Organic growth: +7% YoY change in basis points: CAG Diagnostics Recurring Reported (510 bps) Comparable
Slide 2: 2024 Growth and Financial Performance Outlook
IDEXX Q2 2024 Earnings Highlights (NASDAQ: IDXX) 2024 Growth and Financial Performance Outlook Commentary • Updates full year P&L guidance to incorporate more recent sector growth trends and sustained outlook for strong comparable operating margin and EPS gains ◦ Updates revenue guidance to $3,885 m
Slide 3: U.S. Companion Animal Practice Growth Update
+ + + + + + + U.S. Companion Animal Practice Growth Update As of June 30, 2024 Total Practice Revenue and Visit Growth Weighted Average Year-over-Year % Change Per Practice* 20% 17.5% 15% Practice Revenue 10% 10.9% 6.3% 5.5% 4.6% 5.2% 3.7% 3.3% 3.0% 5% 3.0% 0% Total Visits 1.4% -1.4% -0.8% -5% -2.2%
Slide 4: U.S. Companion Animal Practice Growth Update: Diagnostic Revenue Growth Contributors
+ + + + + + + U.S. Companion Animal Practice Growth Update As of June 30, 2024 Contributors to U.S. Companion Animal Diagnostic Revenue Growth per Practice** Q2’2024 Year-Over-Year Growth (%) + 7.5% + 5.0% - 0.5% - 2.0% + 9.0% + 9.0% Q2’2023 + 0.5% - 0.5% + 6.0% + 10.0% Q2 Average 2019-2022 + 1.0% +